Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05546723 |
Title | LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002) |
Acronym | LMY-920-002 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Luminary Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University Hospitals Seidman Cancer Center | RECRUITING | Cleveland | Ohio | 44106 | United States | Details |